Hopes and optimism were part of the key market drivers at the start of last week’s trading. Investors’ confidence grew stronger amidst central banks kept their monetary policy loose, corporates reported better than expected earnings results, as well as expectations of a wider rollout for the vaccine. The severe weather conditions in the US knocked the country off its feet when parts of its population was left without power and water– causing concerns over the eventual effect this would have on its broader economy. Scepticism and uncertainties dragged down sentiment to leave major markets to end the week on a mixed note.
In The News
- Global financial markets had ended the week on a mixed note, though optimism that global economies will be gradually shifting back to normalcy gave stocks in the financial, and energy sector a boost.
- The US has forecasted a wider rollout of the vaccine, and is targeting to have all Americans vaccinated by July.
- While vaccine targets boosted confidence, economic datapoints flowing out of the US were generally weak with the exception of a surprise jump in retail sales numbers. The 5.3% jump beat the 1.3% rise forecasted by analyst, and was said to be driven by the USD 600 direct payout to the lower, and middle-income Americans. While the recipients had rejoiced in receiving the long awaited aid, critics are pointing out the possibility that the move may lead to overheating of the economy, and a rebound in inflation.
- Severe weather conditions hit part of the US, and caused disruption in power, and water supply. The deep freeze that hit the US state of Texas also caused disruption in oil supply – which helped push oil price briefly above the USD60 per barrel market, before settling the week at USD59.24 per barrel.
- After taking a break for the Lunar New Year holidays, the China market was back in action on Thursday. The China equities market ended the week on a mixed note when the PBOC decided to reduce liquidity from its financial system. The move is seen as a pre-emptive one given that the China economy has regained its footing, thus a withdrawal of earlier stimulus measures is likely to take place.
- The New China Economy took the brunt of the hit, with the S&P New China Sectors ex A Shares sliding 1.01% lower, whilst the HSCEI emerged as the strongest performer with a gain of 1.95% in MYR terms. The strength in the performance of the HSCEI Index provided a boost for the 0832EA, which aims to provide 2X the daily performance of the Index. The HSCEI 2X Leveraged ETF rose 5.7% higher over the week.
- The drop for the NewChina ETF (0829EA) was marginally insulated due to the CNY holiday on the 12th, leaving the performance of the NewChina ETF at 22.93% YTD.
- The usual “migration” of local Chinese was disrupted following the government’s call to discourage travel after a resurgence in cases in the country. This had led to a big jump in delivery services, as well as telco charges, whilst sending numbers for retail and catering services higher YoY.
- China also overtook the US to become Europe’s largest trading partner. Trade volumes reached more than USD 710 billion in 2020, as both the value of exports and imports grew, while trades between Europe and the US dwindled.
- On the domestic front, the momentum stocks stayed resilient to lose marginal ground as compared to the broader market. The 0836EA, which provides exposure into 20 momentum movers within the domestic market has risen 6.23% since the start of the year, whilst the broader KLCI is down 2.6% in MYR terms over the same period.
- As optimism surrounding the reopening of economies returned, we saw investors move out of safe haven’t assets. Bond yields were seen to be on the rise, while Gold price slid lower. The 0828EA tumbled 2.95% over the week in MYR terms as investors turned back towards risk assets.
ETF strategies at TradePlus
A look at the performance of TradePlus ETFs, and major global indices
Learn more about TradePlus ETFs
Disclaimer: This article has been prepared by AHAM Asset Management Berhad (“AHAM Capital”) specific for its use, a specific target audience, and for discussion purposes only. All information contained within this presentation belongs to AHAM Capital and may not be copied, distributed or otherwise disseminated in whole or in part without written consent of AHAM Capital. The information contained in this presentation may include, but is not limited to opinions, analysis, forecasts, projections and expectations (collectively referred to as “Opinions”). Such information has been obtained from various sources including those in the public domain, are merely expressions of belief. Although this presentation has been prepared on the basis of information and/or Opinions that are believed to be correct at the time the presentation was prepared, AHAM Capital makes no expressed or implied warranty as to the accuracy and completeness of any such information and/or Opinions. As with any forms of financial products, the financial product mentioned herein (if any) carries with it various risks. Although attempts have been made to disclose all possible risks involved, the financial product may still be subject to inherent risk that may arise beyond our reasonable contemplation. The financial product may be wholly unsuited for you, if you are adverse to the risk arising out of and/or in connection with the financial product. AHAM Capital is not acting as an advisor or agent to any person to whom this presentation is directed. Such persons must make their own independent assessments of the contents of this presentation, should not treat such content as advice relating to legal, accounting, taxation or investment matters and should consult their own advisers. AHAM Capital and its affiliates may act as a principal and agent in any transaction contemplated by this presentation, or any other transaction connected with any such transaction, and may as a result earn brokerage, commission or other income. Nothing in this presentation is intended to be, or should be construed as an offer to buy or sell, or invitation to subscribe for, any securities. Neither AHAM Capital nor any of its directors, employees or representatives are to have any liability (including liability to any person by reason of negligence or negligent misstatement) from any statement, opinion, information or matter (expressed or implied) arising out of, contained in or derived from or any omission from this presentation, except liability under statute that cannot be excluded.
Warning Statement: A copy of the Prospectus / Supplemental Prospectus for the TradePlus Shariah Gold Tracker and TradePlus S&P New China Tracker, the Prospectus for the TradePlus DWA Malaysia Momentum Tracker and TradePlus MSCI Asia Ex Japan REITs Tracker, as well as the Master Prospectus for the TradePlus NYSE® FANG+™ Daily (2x) Leveraged Tracker, TradePlus NYSE® FANG+™ Daily (-1x) Inverse Tracker, TradePlus HSCEI Daily (2x) Leveraged Tracker and TradePlus HSCEI Daily (-1x) Inverse Tracker (collectively known as the “TradePlus L&I ETFs”) can be obtained at Affin Hwang Asset Management's (“AHAM Capital”) website at www.tradeplus.com.my. Investors are advised to read and understand the contents of the Prospectus dated 28 November 2017 and Supplemental Prospectus dated 2 July 2019 (for TradePlus Shariah Gold Tracker), Prospectus dated 15 January 2019 and Supplemental Prospectus dated 2 July 2019 (for TradePlus S&P New China Tracker), Prospectus dated 9 July 2020 (for TradePlus DWA Malaysia Momentum Tracker), Prospectus dated 9 July 2020 (for TradePlus MSCI Asia Ex Japan REITs Tracker), as well as the Master Prospectus dated 26 November 2019 (for the TradePlus L&I ETFs) before investing. There are fees and charges involved when investing in the funds stated herein. Investors are advised to consider and compare the fees and charges as well of the risks carefully before investing. Investors should make their own assessment of the risks involved in investing and should seek professional advice, where necessary. The price of units and distribution payable, if any, may go down as well as up and past performance of the funds should not be taken as indicative of their future performance. The Securities Commission Malaysia has not reviewed this material and takes no responsibility for the contents of this material and expressly disclaims all liability, however arising from this material.
You may refer to the relevant Licensing Disclosure Statement & Conditions at the respective webpages for each fund available on www.tradeplus.com.my.